Could Viking Therapeutics Next: Will It Challenge Lilly?
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Which Is More Suitable For Aggressive Investors Index Fund Vs Target Date weighs volatility, potential upside, and suitability for growth-focused plans.
28,574 articlesThe race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Archer Aviation takes a bold leap with Halo, a pilotless, hybrid-electric tilt-rotor aircraft developed with Anduril....
Retirees facing Medicare costs and market volatility are reconsidering Roth moves. Experts warn that large roth conve...
SpaceX has sparked huge investor curiosity, but buying SpaceX stock before the next move requires a disciplined plan....
Nu Holdings has shown it can acquire customers at scale, but the real test is monetization quality. This article brea...
ARK Invest placed a sizable bet on Circle amid a sell-off triggered by draft Clarity Act provisions. The move sparked...
SpaceX unveiled a century long strategy spanning launches, Starlink, and AI, pushing the company toward a potential $...
Microsoft’sAI push fuels cloud and enterprise gains even as capital outlays rise and OpenAI losses widen. Analysts ma...
A growing share of crypto wealth sits behind private keys. With no centralized backstop, 2026 could reveal the first ...
Beijing and Hong Kong unveiled a coordinated package to deepen offshore yuan liquidity and gold settlement, signaling...
Apple sidesteps the AI capex race, prioritizing software and on-device AI. Analysts see a bigger iPhone upgrade cycle...
As the 10-year treasury yield approaches 5%, SCHG faces higher discount rates that could compress growth valuations. ...